← Back to all trials
Active Not Recruiting
NCT05863052
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
Conditions: Immune Checkpoint Inhibitors, Metastatic Solid Tumor, Nonsmall Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Gastrointestinal Cancer, Squamous Cell Carcinoma
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Enrollment: 72
Sponsor: University of Oklahoma
Location: Arizona Cancer Center at the Unvieristy of Arizona Tucson Arizona
Summary
The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to future interventional studies.
Eligibility Criteria
Inclusion Criteria:
* above age 18,
* histologically and cytologically confirmed NSCLC, melanoma, head and neck squamous cell carcinoma, gastrointestinal cancers,, renal cell carcinoma, or any other solid tumors where immune checkpoint therapy has been used
* received immunotherapy as part of their treatment
* Self-identified American Indian in ethnicity
* Patients at the Stephenson Cancer Center between 2015 to 2021
Exclusion Criteria:
* patients who did not receive immune checkpoint inhibitor therapy
Source: ClinicalTrials.gov (NCT05863052). StuddyBuddy aggregates publicly available trial information.
